Predictive value of the kinetics of procalcitonin and C-reactive protein for early clinical stability in patients with bloodstream infections due to Gram-negative bacteria.

[1]  T. Welte,et al.  Effects of procalcitonin testing on antibiotic use and clinical outcomes in patients with upper respiratory tract infections. An individual patient data meta-analysis , 2017, Clinical chemistry and laboratory medicine.

[2]  R. Rivera-Fernández,et al.  Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock , 2017, PloS one.

[3]  K. Lewandrowski,et al.  Serial Procalcitonin as a Predictor of Bacteremia and Need for Intensive Care Unit Care in Adults With Pneumonia, Including Those With Highest Severity: A Prospective Cohort Study , 2017, Open forum infectious diseases.

[4]  F. Guo,et al.  Combination of C-reactive protein, procalcitonin and sepsis-related organ failure score for the diagnosis of sepsis in critical patients , 2016, Annals of Intensive Care.

[5]  M. Christ-Crain,et al.  Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia , 2015, Clinical chemistry and laboratory medicine.

[6]  T. Oshima,et al.  Serum Procalcitonin Level and SOFA Score at Discharge from the Intensive Care Unit Predict Post-Intensive Care Unit Mortality: A Prospective Study , 2014, PloS one.

[7]  Hongmin Zhang,et al.  Procalcitonin Kinetics and Nosocomial Pneumonia in Older Patients , 2014, Respiratory Care.

[8]  S. Jaber,et al.  Procalcitonin biomarker kinetics fails to predict treatment response in perioperative abdominal infection with septic shock , 2013, Critical Care.

[9]  P. Schuetz,et al.  Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients , 2013, Critical Care.

[10]  A. Groeneveld,et al.  Changes in Circulating Procalcitonin Versus C-Reactive Protein in Predicting Evolution of Infectious Disease in Febrile, Critically Ill Patients , 2013, PloS one.

[11]  Peter Schlattmann,et al.  Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. , 2013, The Lancet. Infectious diseases.

[12]  Herwig Gerlach,et al.  Patterns and early evolution of organ failure in the intensive care unit and their relation to outcome , 2012, Critical Care.

[13]  S. Lobo.  Sequential C-reactive protein measurements in patients with serious infections: does it help? , 2012, Critical Care.

[14]  F. Tubach,et al.  Procalcitonin to Guide Initiation and Duration of Antibiotic Treatment in Acute Respiratory Infections: An Individual Patient Data Meta-Analysis , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  P. Póvoa,et al.  Patterns of c-reactive protein RATIO response in severe community-acquired pneumonia: a cohort study , 2012, Critical Care.

[16]  A. Del Arco,et al.  Impact of Inadequate Empirical Therapy on the Mortality of Patients with Bloodstream Infections: a Propensity Score-Based Analysis , 2011, Antimicrobial Agents and Chemotherapy.

[17]  P. Póvoa,et al.  C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study , 2011, Critical care.

[18]  E. Ruokonen,et al.  Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study , 2010, Critical care.

[19]  F. Tubach,et al.  Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial , 2010, The Lancet.

[20]  B. Bein,et al.  Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial , 2009, Critical care.

[21]  J. Quenot,et al.  Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome , 2009, Critical care.

[22]  Margaret A Dudeck,et al.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.

[23]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2008, Journal of clinical epidemiology.

[24]  Á. Soriano,et al.  Microbial and clinical determinants of time-to-positivity in patients with bacteraemia. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[25]  J. Burke,et al.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship , 2007 .

[26]  M. Meisner,et al.  Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia , 2006, Critical care.

[27]  P. Póvoa,et al.  Pilot study evaluating C-reactive protein levels in the assessment of response to treatment of severe bloodstream infection. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  D. Schaer,et al.  Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes* , 2004, Critical care medicine.

[29]  M. Meisner,et al.  Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction , 2004, Critical care.

[30]  M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive care medicine.

[31]  J. Vincent,et al.  Serial evaluation of the SOFA score to predict outcome in critically ill patients. , 2001, JAMA.

[32]  H. Schächinger,et al.  Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit , 2000, Critical care medicine.

[33]  J. Vincent,et al.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.

[34]  V. Yu,et al.  Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. , 1989, The American journal of medicine.

[35]  H. Akaike.  A new look at the statistical model identification , 1974 .

[36]  Clinical,et al.  Performance standards for antimicrobial susceptibility testing , 2019 .

[37]  M. Nijsten,et al.  Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. , 2018, The Lancet. Infectious diseases.

[38]  M. Ferraro.  Performance standards for antimicrobial susceptibility testing , 2001 .

[39]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.